Teva, Alvotech Secure FDA Approval for Stelara Biosimilar with Early 2025 Launch
Pictured: FDA's signage outside its office in Washington, DC/iStock, JHVEPhoto The FDA on Tuesday approved Alvotech and Teva Pharmaceuticals’ Selarsdi (astekinumab-aekn), a biosimilar to Johnson & Johnson’s blockbuster immunotherapy Stelara ( …